Radiotherapy for non-cancer diseases: benefits and long-term risks.
Juliette ThariatMark P LittleLydia B ZablotskaPamela SamsonM Kerry O'BanionKlervi LeuraudCarmen BergomGilles GiraultOmid AzimzadehSimon BoufflerNobuyuki HamadaPublished in: International journal of radiation biology (2024)
A growing body of evidence has suggested that radiation represents a double-edged sword, not only for cancer, but also for non-cancer diseases. At present, clinical evidence has shown some beneficial effects of radiotherapy for ventricular tachycardia, but there is little or no such evidence of radiotherapy for other newly proposed non-cancer diseases (e.g. Alzheimer's disease, COVID-19 pneumonia). Patients with ventricular tachycardia and COVID-19 pneumonia have thus far been treated with radiotherapy when they are an urgent life threat with no efficient alternative treatment, but some survivors may encounter a paradoxical situation where patients were rescued by radiotherapy but then get harmed by radiotherapy. Further studies are needed to justify the clinical use of radiotherapy for non-cancer diseases, and optimize dose to diseased tissue while minimizing dose to healthy tissue.
Keyphrases
- early stage
- papillary thyroid
- locally advanced
- radiation therapy
- radiation induced
- squamous cell
- coronavirus disease
- sars cov
- newly diagnosed
- end stage renal disease
- childhood cancer
- ejection fraction
- intensive care unit
- young adults
- peritoneal dialysis
- cognitive decline
- prognostic factors
- acute respiratory distress syndrome
- mild cognitive impairment
- combination therapy
- patient reported
- respiratory syndrome coronavirus